Murine monoclonal antibodies (mAbs) M38 and L31 define two epitopes of a surface protein of activated lymphocytes and monocytes. It has been shown that M38 also defines a crossreactive epitope of human immunodeficiency virus type 1 (HIV1) gp120 (Beretta et al., 1987 . Eur. J. Immunol. 17:1793 . The mAb inhibits syncytia formation driven by HIV-1-infected cells. The surface protein was demonstrated to be a class I MHC ot chain, by sequence analysis of the corresponding cDNA and by immunological means. The epitopes defined by mAbs M38 and L31 are monomorphic and hidden (i.e., inaccessible to antibodies) on native HLA molecules expressed by resting cells, but can be evidenced on denatured proteins by Western blot analysis. The two epitopes become accessible after activation processes havebeen implemented, likely reflecting a conformational alteration of at chains (such as that described by Schnabl et al. 1990 . J Exp. Med. 171:1431) . Consistent with molecular data are the results offunctional analysis, which indicate that the molecule recognized by M38 and L31 is a gate for pleiotropic negative signals, since the two mAbs were shown to inhibit monocyte antigen presentation and lymphocyte mitogenic proliferation, respectively.
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Summary
Murine monoclonal antibodies (mAbs) M38 and L31 define two epitopes of a surface protein of activated lymphocytes and monocytes. It has been shown that M38 also defines a crossreactive epitope of human immunodeficiency virus type 1 (HIV1) gp120 (Beretta et al., 1987 . Eur. J. Immunol. 17:1793) . The mAb inhibits syncytia formation driven by HIV-1-infected cells. The surface protein was demonstrated to be a class I MHC ot chain, by sequence analysis of the corresponding cDNA and by immunological means. The epitopes defined by mAbs M38 and L31 are monomorphic and hidden (i.e., inaccessible to antibodies) on native HLA molecules expressed by resting cells, but can be evidenced on denatured proteins by Western blot analysis. The two epitopes become accessible after activation processes havebeen implemented, likely reflecting a conformational alteration of at chains (such as that described by Schnabl et al. 1990 . J Exp. Med. 171:1431) . Consistent with molecular data are the results offunctional analysis, which indicate that the molecule recognized by M38 and L31 is a gate for pleiotropic negative signals, since the two mAbs were shown to inhibit monocyte antigen presentation and lymphocyte mitogenic proliferation, respectively. H IV infection of susceptible cells starts with the interaction ofviral gp120 with the CD4 molecule (1) (2) (3) . Since CD4 belongs to the Ig superfamily, whose members are involved in regulatory interactions essential for the immune system function (4-6), the specificity ofgp120 for this molecule could be central for the virus in evading the host immune response.
Beside the depletion of CD4+ cells due to HIV cytopathic effects, other gp120-related mechanisms for amplification of immune damage have been proposed : killing ofbystander cells induced by soluble gp120 (7, 8) , anti-CD4 autoantibodies induced by CD4-like idiotopes expressed within the env-specific repertoire (9) , synergism between gp120 and anti-gp120 antibodies in blocking T cell activation (10) , and blockade of the differentiation of CD4+CD8+ thymocytes into CD4+ CD8 -T lymphocytes secondary to gp120 binding to CD4 (11, 12) .
CD4 is a ligand of class II MHC and interacts with other proteins in the context of a multimolecular complex (13, 14) . HIV might have evolved its specificity for CD4 by mimicry of a physiological ligand of CD4 . Experimental evidence of serological crossreactivity between viral envelope and human epitopes have already appeared in two independent reports. One case is the identification of homologous regions in HIV-1 gp41 and human class II MHC (/3-1 domain) . A fraction (36%) of AIDS patient sera was shown to contain antibodies reacting with a class II-derived peptide and with native class II antigens (15) . Further, a gp120-specific mAb, M38, was shown to crossreact with a surface protein of activated human monocytes endowed with negative signaling potentials (16) .
The present work describes by biochemical, immunological, and genetical means the crossreactive human surface protein defined by mAb M38. Such a molecule resulted in being a class I MHC heavy chain, present on activated immuno-cytes in a form that differs from that of HLA molecules on resting cells, likely corresponding to the conformational alteration of ca chains (not associated with 02m) recently described by Schnabl et al . (17) . We present evidence that such conformationally altered molecules might be involved in functional regulatory mechanisms .
Materials and Methods
Monoclonal Antibodies. mAbs OKT3, -4, -8, and -9 were purchased from Ortho Diagnostics Systems, Inc., (Raritan, NJ), and Leu-3a was from Becton Dickinson & Co. (Mountain View, CA). The anti TAC DMS-1 (18) and the anti-CD3 UCTH-1 (19) were kindly provided by Drs. Smith and Beverly (ICRF, London), respectively. mAb 01 .65 (20) , specific for a common determinant of HLA-A, -B, -C molecules, and mAb R1 .30, specific for 02m (20) , were kind gifts of Dr. Malavasi (Department of Genetics, University of Torino, Italy), mAb CR11 .351, specific for a polymorphism determinant of HLAA2 (21) , was a kind gift of Dr. Russo (Columbia University, New York). M38, L31, and D28 were derived from the same fusion (16) ; D28 was used as a control of irrelevant specificity.
Cells. Human PBMC, isolated by Ficoll-Hypaque discontinuous gradient centrifugation were cultured after stimulation with OKT3 and rabbit anti-mouse Ig antibodies (22) or with 5 Aglml Con A to obtain activated lymphocytes . Rex cells, a human T lymphoblastoid cell line, were a kind gift of Dr. Acuto (Department of Immunology, Pasteur Institute, Paris) . 81351 (LAV) cells, which harbor a single integrated copy of a pot mutant of HIV-1 (LAV) and produce defective, uninfectious virions (23), were a kind gift of Dr. Folks (Center for Disease Control, Atlanta, GA). MOLT3 cells were a kind gift of Dr. De Rossi (Oncology Institute, University of Padova, Italy.
Cytofuorimetry. Lymphocytes of 8E51(LAV) cells were washed and resuspended in RPMI 1640 containing 20% normal human serum. Cells (106 cells/200 Al) were incubated on ice for 30 min with the appropriate dilution of mAb. After two washings in RPMI 1640, FITC-conjugated rabbit anti-mouse Igs (Dakopatts a/s Glostrup, Denmark) were added and cells were incubated 30 min on ice. Washed cells were fixed in 5% paraformaldehyde and applied to a Spectrum III flow cytometer (Ortho Diagnostics Systems, Inc.) . For the blocking experiment to demonstrate that M38 could bind both the viral and the cellular antigens, Con A-activated lymphocytes were used : 1 leg of M38 (or 01.65) was preincubated (30 min at room temperature) with an eightfold molar excess (5 Fcg) of recombinant soluble gp160 (Transgene, Strasbourg) . A FACScana (Becton Dickinson & Co .) was used for this experiment .
Radiolabelled mAb Cell Binding Assay. mAbs were purified from ascitic fluids by (NH4)2SO4 precipitation and protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ) affinity adsorption and radioiodinated using Enzymobeads (Bio-Rad Laboratories, Richmond, CA) and Na '25 1 (Amersham Corp ., Arlington Heights, IL). For the cell binding assay, cells were resuspended at 5 x 106/ml in RPMI 1640 supplemented by 5% rabbit serum; 100 Al of the cell suspension was loaded onto a two-step gradient in 0.3-ml tubes (lower layer: 90% FCS and 10% sucrose; upper layer: 80% silicon oil and 20% mineral oil) with appropriate dilutions of radiolabeled mAbs and competitors . After a 30-min incubation at 37°C, cell-bound and free radioactivity was determined after centrifugal cell separation .
Radioiodination, Immunoprecipitation, andSDS/PAGE. Cells were radioiodinated by the lactoperoxidase method and lysed in digitonin lysis buffer (10 mM Tris-HCI, pH 7.5 ; 5 mM EDTA ; 0.15 M NaCl ; 54 gp120 Mimics a Hidden Monomorphic Epitope 2% digitonin; 10 MM NaF; 1 mM PMSF ; 10 mM iodoacetamide; 5 hg/ml leupeptin, and pepstatin A) . The lysates were adsorbed on mAb-Affigel beads (Bio-Rad Laboratories) for 1 h at 4°C. After four washes in Digitonin lysis buffer, the material was eluted from the beads with SDS/PAGE sample buffer (with or without 2% 02m) . SDS/PAGE was run using vertical slab gels and 10% acrylamide. Immunoabsorption Assay. Activated lymphocytes (3 x 10'/ml) were suspended in Triton lysis buffer (20 mM Tris-HCI, pH 7.4 ; 0.15 M NaCl ; 10 mM NaF; 2.5 mM EDTA ; 1% Triton X-100; 10 mM iodoacetamide; 1 mM PMSF ; 5 hg/ml leupeptin) at 4°C for 30 min. Postnuclear supernatants were loaded on affinity columns of Affigel (BioRad Laboratories) coupled to the indicated mAbs (3 mg/ml of packed beads) . The first 3 ml effluent and the SDSeluted material were acetone precipitated and resuspended in SDS/PAGE sample buffer for Western Blot analysis with "5I-M38 and "'I-L31.
Syncytia Formation Assay. 81351 (LAV) cells and MOLT3 cells were grown in RPMI 1640 supplemented by 10% FCS to concentrations of 106 cells/ml, washed in medium, mixed in 1:2 proportions, and distributed in V-shaped microtiter wells (1 .6 x 105 cells/well) with the addition of mAbs or of antisera in appropriate dilutions. After a 30-min incubation at 37°C, the cells were sedimented by centrifugation and incubated as a pellet for 3 h at 37°C. Syncytia of dimensions of 10 to >100 cells were scored with an inverted microscope after transfer of the resuspended pellet to flat-bottomed well microtiter plates. In uninhibited control samples, 100-150 large Syncytia/well were counted.
Immunoselection of Recombinant Phages "5I-M38 and -L31. Recombinant phage plaques (2 x 106) of Agtll cDNA expression library from human PHA-stimulated T lymphocytes (HL1031b ; Clontech Laboratories Inc., Palo Alto, CA) were screened according to Young and Davis (24) with minor modifications : dry milk was used to overcoat the filters, and directly labeled antibody (106 cpm/ml of either 1251-L31 or '2 'I-M38, both at a specific activity of 41 mCi/mg) was used instead of cold antibody and '251-Staphylococcus Protein A.
Subdoning and Sequencing of cDNA . A phage clone, positive with 125 1-L31 and 125 1-M38 and negative with an irrelevant antibody, was chosen for further analysis . The insert was subdoned into the EcoRI site of the plasmid vector pUC8, and the recombinant plasmid (PL208) was sequenced according to the method of Sanger et al . (25) . A Data Bank search was done with the FASTN algorithm to compare the DNA sequence with the EMBL data bank .
Lymphocyte Proliferation Assays . Tetanus toxoid presentation experiments were performed as described (16); adherent monocytes (2 x 104/assay) were pulsed with tetanus toxoid (20 ng/assay), antibodies were used as 1:100 ascites and purified T cell (105/assay) proliferation was evaluated at day 5 by ['H]thymidine incorporation .
Mitogenic proliferation of PBMC (2 x 10 5/assay) stimulated by crosslinked OKT3 or by other mitogens was evaluated by ['H]thymidine incorporation at day 4. Antibodies were used as 1:200 ascites and added to the culture twice, at day 0 and at day 2. 11,2 production by human PBMC cultured for 18 h after stimulation by crosslinked OKT3 was evaluated as described by Gillis et al . (26) .
Results
Characterization of mAb L31. mAb L31 was derived from the same HIV-immunized mouse that yielded M38 (16) . It was selected for its strong reactivity in commercial HIVELISA and was shown to bind the surface of activated human PBMC by cell binding assays and by flow cytometry. Since these properties were similar to those described for M38, we compared the specificities of the two antibodies in Western blot and radioimmunoprecipitation assays.
The reactivity pattern of 125 1-L31 and -M38 on HIV-1, HIV-2, and HTLV1 Western blot strips ( Fig. 1 A) proved to be similar, even though not identical: both antibodies reacted with a 45-kD protein band, while only M38 recognized the env product of HIV-1 (but not that of the other two retroviruses) . Radioimmunoprecipitations of lysates from surface-labeled activated lymphocytes demonstrated that both L31 and M38 precipitate similar (likely identical) 45-kD bands and fainter 90-kD bands ( Fig . 1 B) .
The number of antibody binding sites on the lymphocyte surface was found to increase 10-40-fold after polyclonal lymphocyte stimulation by OKT3 (Fig. 2 A) . The affinity of the interaction (Kd = 5 nM) was deducted by Scatchard plot analysis of equilibrium binding assays. The L31-defined antigen, undetectable at day 0 by flow cytometry analysis, was detected on the majority of cells at day 3 ( Fig . 2 B) . Conversely, Western blot analysis of whole cell lysates with L31 ( Fig. 2 B) demonstrated quantitatively similar reactivities in resting and activated lymphocytes. Analogous results were obtained with M38 (data not shown) . These results indicate that the protein is present in a fashion inaccessible to antibodies in resting cells . The epitopes recognized by the two mAbs become accessible on the cell surface only as a consequence of mitogenic activation.
M38 and L31 React with the Same Cell Protein. To confirm 5 5 Grassi et al . the hypothesis that M38 and L31 recognize two epitopes of the same cell protein, lysates from activated lymphocytes were adsorbed onto four immunoaffinity columns bearing L31, M38, and two control irrelevant isotype-matched mAbs, respectively. Either effluents or SDS-released eluates were analyzed by immunoblotting with 125 1-M38 (Fig. 3 A) or 1251-L31 (Fig. 3 B) . The L31 column (but not those bearing control antibodies) caused a major immunodepletion in the effluent (Fig. 3, lanes a) and an almost quantitative recovery of the 45-kD band in the eluate (lanes b). The protein band was decorated equally well by either antibody. Similar results were obtained with the M38 column, although this antibody was less efficient than L31 in retaining the 45-kD protein .
These results indicate that the cell protein defined by M38 is identical to that recognized by L31 . Fine Specificity ofM38 and L31 . The interaction of M38 with the cellular antigen on the surface of activated lymphocytes (measured by flow cytometry) could be significantly reduced by soluble recombinant gp160; in the same conditions, the binding of mAb 01 .65 (20) , specific for a common determinant of HLA-A, -B, -C molecules was unaffected (Fig. 4) .
Also unaffected was the binding of L31 (data not shown) .
To further analyze the specificities of M38 and L31 with respect to HIV 1, the two antibodies were used in gp120-related assays on living cells . 8E51(LAV) cells and MOLTS cells, sedimented together in Vshaped wells and incubated as a pellet, form large syncytia . The assay can be inhibited by anti-CD4 mAbs and by patients sera containing neutralizing antibodies . The addition of mAb M38 resulted in a marked inhibitory effect (Fig. 5 A) , while L31 and a number of mAbs (specific for HIV antigens or of irrelevant specificity) had no effect at all . These data, together with the cytofluorimetry findings on 8E51(LAV) cells, labeled by M38 and by other anti-gp120 mAbs, while not by L31 (Fig. 5 B) , confirm the differential anti-gp120 specificity of M38 . recombinant a-galactosidase was confirmed by Western blot analysis of IPTG-induced phage lysates (data not shown) .
The insert (1,549 bp) was subcloned into the vector pUC8, and the recombinant plasmid (PL208) was then sequenced . The insert sequence contained an open reading frame (between nucleotide residues 10 and 1108) (Fig. 6 ) coding for a protein of 366 aminoacids. A data bank comparison of the nucleotide sequence revealed a high degree of homology with the class I MHC gene family. The sequence is not identical to any of the already sequenced alleles, while maximal homology was found with the alleles of the C locus.
A direct comparison to all the available C alleles amino acid sequences (27, 28) is seen in Fig. 7 . A 96% homology was found with allele Cb-1. The protein contains the characteristic six domains of class I MHC heavy chains (leader peptide, ci 1, a 2, (x 3, transmembrane, and cytoplasmic domains) and the three C-specific residues (val-52, glu-183, and glu-268) . The five cysteine residues and the glycosylation site (gin-87) are conserved . Moreover, all but two variations from the consensus are in residues that show the same amino acid substitution in at least one other sequenced C allele ; the two variations unique to this sequence are trp-14 and glu-49 . These data strongly suggest that the sequenced polypeptide is a product of an allele of the HLA-C locus.
M38 and L31 Recognize "Hidden" Epitopes of Class I MHC a Chains. An immunological approach to confirm that the protein defined by M38 and L31 is a class I MHC heavy chain was based upon immunoprecipitations from detergent lysates of Rex cells (reactive with both M38 and L31) using either mAb 01 .65 (20) , specific for a common determinant of HLAA, -B, -C molecules, or mAb R1 .30, specific for 02m (20) . QmAb OKT4 was included as a control. Both precipitates and supernatants were analyzed by immunoblotting with t251-L31. As can be seen in Fig . 8 conformations. The conformation coprecipitable with 02m and inaccessible to M38 and L31 is identical to that ofresting cells, while the second one is not coprecipitable with 02m and bears the "hidden" epitopes now accessible to antibodies .
The above reported findings (and their interpretation) are very similar to those of Schnabl et al. (17) , who demonstrated that activated T lymphocytes express class I MHC heavy chains Transmembrane region Cytoplasmatic tail Figure 8 . Demonstration that the L31-defined epitope is present on denatured HLA chains. Postnuclear supernatants of Rex cell Triton lysates were loaded on affinity columns of Affigel coupled with the indicated mAbs. mAb 01 .65 is specific for a common determinant of HLA-A, -B, -C molecules ; mAb R1 .30 is specific for 02m and mAb OKT4 was included as a control . The precipitate (p) and the supernatant (s) were subjected to Western Blot analysis with 1251-1,31 .
not associated with 02M . This was inferred on the basis of the reactivity of mAb LA45 with SDS-denatured, but not associated with 02m, heavy chains and with heavy chains expressed on the surface of activated (but not resting) lymphocytes .
The epitopes recognized by M38 and L31 seem to be similar to that recognized by LA45 ; indeed, neither our antibodies (Fig . 1 B) , nor LA45, coprecipitated ß2m. Conversely, the anti-ß2m antibody R1 .30 immunoprecipitated only a fraction of the L31-reactive material (Fig. 8) , in close analogy with the observation by Schnabl et al. (17) with mAb W6/32, which immunoprecipitates only ß2m-associated heavy chains.
Functional Consequences of the Interaction of M38 and L31 with Immunocytes. Schnabl et al . (17) have suggested that the conformational alteration of class I proteins upon T cell activation might have some important functional implications . In light of our previous finding of antigen presentation inhibited by M38 (16), we investigated the functional effects elicited by interaction of the two antibodies with immunocytes. Indeed, several mAbs reactive with class I monomorphic determinants were reported to influence lymphocyte proliferation in different experimental models (20, (29) (30) (31) . Antigen presentation was not inhibited by the addition of L31, at variance with the influence of M38 (Fig. 9 A) . Further, L31 inhibited lymphocyte proliferation induced by polyclonal mitogenic stimuli . The addition of L31 (but not of M38) significantly inhibited the mitogenic response of human lymphocytes challenged with either Con A or anti-CD3 (Fig.  9 B) . Such inhibition was concomitant to a reduction in IL-2 production (Fig. 9 C) . This result is concordant with the finding that exogenously added IL-2 could reverse the inhibition of lymphocyte proliferation by L31 (data not shown) . 59 Grassi et al . The interaction of CD4 to class II MHC and to HIV-1 gp120 has been recently reported as involving different domains of the molecule (12, 32) . However, the finding that soluble gp120 can inhibit CD4-class II MHC binding raises the possibly that the CD4 binding sites for the two ligands may be overlapping .
To verify the hypothesis that HIV could mimic a physiological ligand of CD4, we analyzed a panel of murine mAbs raised against HIV-1 looking for crossreactivities between env products and activated human PBMC. The expectation to find a crossreactivity with class II MHC molecules was not fulfilled : instead, we characterized mAb M38, which defines an epitope shared by HIV-1 gp120 and by class I MHC heavy chains . Such a determinant proved to be monomorphic, common to HLAA, -B, -C molecules and accessible to the antibody on activated, but not resting, immunocytes .
We had earlier reported that the anti-gp120 specificity of mAb M38 was shared with an "activation protein" present on human monocytes (16) . We then provided a tentative definition of the human target molecule as an "8041) protein", which was the most prominent band in radioimmunoprecipitation from metabolically labeled cells. The 45-kD minor band was also present, but was at the time interpreted as a nonspecific signal and overlooked . The findings obtained by several analytical approaches confidently demonstrate that the reactive protein has a molecular mass of 45 kD. The previous conclusions are likely to be referable to incomplete sample reduction : dimerization of HLA molecules in tissue extracts (33) and molecular masses of 90/45 kD under nonreducing conditions have been reported for HLA molecules (17) .
Here, we report the results obtained from the analysis of L31, a mAb derived from the same fusion yielding M38. L31 proved to be specific for the same cell protein recognized by M38 (Fig. 3) , even though lacking the crossreactivity with HIV-1 gp120 . The anti-gp120 specificity of M38 was documented by western blot analysis on SDS-denatured proteins ( Fig. 1) and by assays on live HIVinfected cells (i.e., inhibition of syncytia formation and cytofluorimetry) (Fig. 5) . M38 inhibited syncytia formation between 8E51(LAV) and MOLT3 cells, a CD4-dependent reaction, although it did not inhibit the infectivity of free virus, as already reported (16) . This finding confirms that virus penetration and syncytia formation are distinct, discrete reactions, although with common steps. The cellular protein defined by M38 and L31 could be included among the products of class I MHC. This was inferred by sequence analysis ofthe cDNA (Figs. 6 and 7 ) from a recombinant phage expressing the epitopes recognized by the two antibodies and by immunoblotting with L31, the precipitates of mAb 01.65 (anti-HLA-A, -B, -C), of mAb R1.30 (anti-02m) (Fig. 8) , and of mAb CR11.351 (anti-HLAA2) (20, 21) . The two epitopes defined by L31 and M38 could be classified as monomorphic and common determinants of HLA-A, -B, and -C molecules. These findings explain the presence of the M38-and 1,31-defined protein in the retrovirus preparations used for Western blots (Fig. 1) ; as demonstrated by Gelderblom et al. (34), HLA proteins are present in retroviral virions.
The class I molecule recognized by the two mAbs on the surface of activated immunocytes could not be assimilated to conventional HLA molecules, since the corresponding epitopes appear to be hidden in HLA molecules present on the surface of resting immunocytes . A strikingly similar situation has recently been reported by Schnabl et al. (17) . They demonstrated the reactivity ofmAb LA45 with SDS-denatured (but not with 02m-associated) a chains and with a chains expressed on the surface of activated (but not resting) lymphocytes. By differential immunoprecipitations and "independent capping" experiments, they concluded that activated T lymphocytes express class I MHC heavy chains not associated with 02m, together with "conventional" 02m-associated HLA molecules. Analogous results and conclusions were reached by Smith and Barber in the mouse system (35) .
The "hidden"epitopes recognized by our mAbs M38 and L31 seem to be, in all their properties, similar to that recognized by LA45 and, indeed, none of the three antibodies coprecipitated 02m. Immunohistochemistry analysis of M38 and L31 reactivity indicates that the tissue distribution is completely different from that of mAbs specific for monomorphic HLA-A, HLA-B, or for determinants common to HLA-A, -B, -C products (P G. Natali, personal communication) .
Schnabl et al. (17) hypothesize that the loss of 02m and the conformational alteration ofclass I MHC proteins upon T cell activation might have some important functional implications. Indeed, this issue has been already addressed in our previous work, where we showed that M38 inhibited antigen presentation (16) . We have now expanded that initial observation by studying the functional consequence of the interaction of the two antibodies in lymphocyte proliferation assays. The results indicate that L31 treatment is associated with significant inhibitory effects, which are paralleled by a marked reduction of IL-2 production (Fig. 8) . It is noteworthy that the interactions ofthe two antibodies with the target epitopes had distinct and independent effects .
The eveptual relevance of the crossreactivity between HIV-1 gp120 and 02M-less class I proteins is still obscure, but two of the findings reported herein make it, in our opinion, a worthwhile field of further research . These are : (a) the involvement ofthe M38-defined gp120 epitope in syncytia formation; and (b) the involvement of 02M-less class I proteins in regulatory mechanisms related to fundamental immunocyte functions. Furthermore, it is known that lymphocyte activation is required to make the cell susceptible to HIV-1 infection ; this could depend upon the requirement for activation products such as /32m-less class I proteins.
